Atazanavir 300 mg + Ritonavir 100 mg
This combination pairs a protease inhibitor with a pharmacokinetic enhancer to improve drug exposure and therapeutic effectiveness in the management of HIV-1 infection, in line with established treatment guidelines.
Product Details
Therapeutic Class
Protease Inhibitor (Atazanavir)
Pharmacokinetic Enhancer (Ritonavir)
Indication
Treatment of HIV-1 infection in adults and adolescents as part of combination antiretroviral therapy (ART), in accordance with WHO and NACO recommendations.
Dosage & Administration
Atazanavir 300 mg boosted with Ritonavir 100 mg once daily, or as prescribed by a healthcare professional.
To be used strictly as part of a combination ART regimen.
Storage
Store below 30°C in a dry place, protected from light and moisture.
Disclaimer
Prescription medicine. To be used only under medical supervision and in line with WHO and NACO treatment guidelines.
Pack Size
30 Tablets